Trulieve stock trades at EUR 9.90 ahead of November 5 results
Published on 11/03/2026 at 14:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTrulieve prepares for quarterly results
- Trulieve will release third-quarter 2026 financial results on Thursday, November 5.
- CEO Kim Rivers and CFO Jan Reese will review financial and operating results during the conference call.
Trulieve Cannabis is heading into its third-quarter 2026 results after announcing a conference call for Thursday, November 5. Trulieve stock traded at EUR 9.90 on Lang & Schwarz at 14:10 CET on Tuesday, November 3, 2026.
In a release published October 6, Trulieve said the financial results would be released before the 8:30 a.m. Eastern Time conference call. Chairman, Founder and CEO Kim Rivers and CFO Jan Reese are scheduled to review the company's financial and operating results.
Results set the next market focus
The November 5 release will give investors a fresh view of Trulieve's third-quarter performance. The company operates as a vertically integrated U.S. cannabis business with medical marijuana operations in Florida, Georgia, Pennsylvania and West Virginia, according to the investor release.
Investors can follow the real-time quote of Trulieve stock as the results approach.
Trulieve Cannabis stock at a glance
- Company: Trulieve Cannabis Corp.
- ISIN: US89790E1064
- Input ticker: TRUL
- NYSE listing: TRLV
- Lang & Schwarz quote: EUR 9.90 at 14:10 CET on November 3, 2026
- Next event: Third-quarter 2026 results call on November 5, 2026 at 8:30 a.m. Eastern Time
U.S. equities are monitored against the S&P 500 as the company approaches its scheduled update.
